# FDA Inspection 1180501 - Vitalant - September 20, 2022

Source: https://www.keypedia.com/records/fda_inspections/vitalant/2d4674c8-6b4e-4a76-82b0-a9616d5ce81f
Source feed: FDA_Inspections

> FDA Inspection 1180501 for Vitalant on September 20, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1180501
- Company Name: Vitalant
- Inspection Date: 2022-09-20
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1257839 - 2024-12-20](https://www.keypedia.com/records/fda_inspections/vitalant/32a85357-fcbb-49c7-9e8b-20557e488dd4)
- [FDA Inspection 1257839 - 2024-12-20](https://www.keypedia.com/records/fda_inspections/vitalant/80e857f7-f46f-4ec2-abb5-fa3e5d7b7959)
- [FDA Inspection 1042847 - 2018-02-05](https://www.keypedia.com/records/fda_inspections/vitalant/6353fdd9-0037-4ff0-8d7f-749207f50078)
- [FDA Inspection 958214 - 2016-01-28](https://www.keypedia.com/records/fda_inspections/vitalant/6526648e-8d10-4d83-863e-e8dc8261bc75)
- [FDA Inspection 867653 - 2014-02-25](https://www.keypedia.com/records/fda_inspections/vitalant/e5946ee2-ddef-4ecf-ae23-278bf6f779ff)

Company: https://www.keypedia.com/companies/vitalant/663bdbfa-a7c2-4d01-8c11-18d3c5be2faa

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d